Detail akcie NeurOne Med Tech Rg online

Business Summary: NeuroOne Medical Technologies Corporation is a medical technology company. It is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. It may also pursue applications for other areas such as depression, mood disorders, incontinence and artificial intelligence. Its products include Evo cortical electrode technology for recording, monitoring, and stimulating brain tissue for up to 30 days; Evo sEEG electrode technology for temporary (less than 30 days) use with recording, monitoring, and stimulation equipment for the recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain, and OneRF ablation system for creation of radiofrequency lesions in nervous tissue for functional neurosurgical procedures.
Financial Summary: BRIEF: For the fiscal year ended 30 September 2025, Neuroone Medical Technologies Corp revenues increased from $3.5M to $12.1M. Net loss decreased 71% to $3.6M. Revenues reflect Product revenue increase from $3.5M to $9.1M. Lower net loss reflects SURGICAL & MEDICAL INSTRUMENTS & APPARATUS segment loss decrease of 64% to $4.2M. Basic Earnings per Share excluding Extraordinary Items increased from -$0.46 to -$0.09.